Cangene's structure and diverse technology base provides flexibility
when responding to the ever changing biotechnology industry. Cangene
is focused on its core strengths;
Hyperimmunes
Manufacturing specialty plasma-based products. Antibodies purified
from human plasma for therapeutic and preventative uses.
Contract Manufacturing
Providing cGMP-manufacturing services. Offering start-to-finish manufacturing ranging from research and product development, through fermentation and purification to final formulation, fill and finishing.
Biodefense
Supplying biodefense products to support the stockpile programs of governments worldwide.
WHAT: Q3 Earnings Announcement WHEN: 2009-06-12 11:00 ET English Event
